Entry |
|
Name |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
Product |
|
Generic |
|
Component |
Amlodipine besilate [DR: D00615], (Atorvastatin calcium hydrate [DR: D02258] | Atorvastatin calcium [DR: D00887] | Atorvastatin calcium propylene glycol solvate [DR: D11095])
|
Class |
Hypolipidemic agent
DG01946 Hypolipidemic agent
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
Remark |
Therapeutic category: | 2190 |
|
Efficacy |
Antihyperlipidemic, Antihypertensive |
Disease |
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10B LIPID MODIFYING AGENTS, COMBINATIONS
C10BX Lipid modifying agents in combination with other drugs
C10BX03 Atorvastatin and amlodipine
D08488 Amlodipine besilate and atorvastatin calcium <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Cardiovascular Agents, Combinations
Amlodipine Besylate/ Atorvastatin Calcium
D08488 Amlodipine besilate and atorvastatin calcium
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
219 Miscellaneous
2190 Miscellaneous
D08488 Amlodipine besilate and atorvastatin calcium
Drug groups [BR:br08330]
Hypolipidemic agent
DG01946 Hypolipidemic agent
D08488 Amlodipine besilate and atorvastatin calcium
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D08488 Amlodipine besilate and atorvastatin calcium
Drug classes [BR:br08332]
Cardiovascular agent
DG01946 Hypolipidemic agent
D08488 Amlodipine besilate and atorvastatin calcium
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08488
|
Other DBs |
|
LinkDB |
|